Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

PRDM14 controls X-chromosomal and global epigenetic reprogramming of H3K27me3 in migrating mouse primordial germ cells.

Mallol A, Guirola M, Payer B.

Epigenetics Chromatin. 2019 Jun 20;12(1):38. doi: 10.1186/s13072-019-0284-7.

2.

Genome-wide identification of autosomal genes with allelic imbalance of chromatin state.

Savol AJ, Wang PI, Jeon Y, Colognori D, Yildirim E, Pinter SF, Payer B, Lee JT, Sadreyev RI.

PLoS One. 2017 Aug 10;12(8):e0182568. doi: 10.1371/journal.pone.0182568. eCollection 2017.

3.

X-chromosome activity in naive human pluripotent stem cells-are we there yet?

Khan SA, Audergon PNCB, Payer B.

Stem Cell Investig. 2017 Jun 13;4:54. doi: 10.21037/sci.2017.06.03. eCollection 2017. No abstract available.

4.

A high-throughput small molecule screen identifies synergism between DNA methylation and Aurora kinase pathways for X reactivation.

Lessing D, Dial TO, Wei C, Payer B, Carrette LL, Kesner B, Szanto A, Jadhav A, Maloney DJ, Simeonov A, Theriault J, Hasaka T, Bedalov A, Bartolomei MS, Lee JT.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14366-14371. doi: 10.1073/pnas.1617597113. Epub 2016 Nov 23.

5.

Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP/TGF-β superfamily as a regulator of XIST expression.

Sripathy S, Leko V, Adrianse RL, Loe T, Foss EJ, Dalrymple E, Lao U, Gatbonton-Schwager T, Carter KT, Payer B, Paddison PJ, Grady WM, Lee JT, Bartolomei MS, Bedalov A.

Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1619-1624. doi: 10.1073/pnas.1621356114. Epub 2017 Jan 31.

6.

EPOP Functionally Links Elongin and Polycomb in Pluripotent Stem Cells.

Beringer M, Pisano P, Di Carlo V, Blanco E, Chammas P, Vizán P, Gutiérrez A, Aranda S, Payer B, Wierer M, Di Croce L.

Mol Cell. 2016 Nov 17;64(4):645-658. doi: 10.1016/j.molcel.2016.10.018.

7.

Developmental regulation of X-chromosome inactivation.

Payer B.

Semin Cell Dev Biol. 2016 Aug;56:88-99. doi: 10.1016/j.semcdb.2016.04.014. Epub 2016 Apr 22. Review.

PMID:
27112543
8.

Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.

Handisurya A, Kerscher C, Tura A, Herkner H, Payer BA, Mandorfer M, Werzowa J, Winnicki W, Reiberger T, Kautzky-Willer A, Pacini G, Säemann M, Schmidt A.

PLoS One. 2016 Jan 6;11(1):e0145319. doi: 10.1371/journal.pone.0145319. eCollection 2016.

9.

Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failure.

Mandorfer M, Steiner S, Schwabl P, Payer BA, Aichelburg MC, Grabmeier-Pfistershammer K, Trauner M, Reiberger T, Peck-Radosavljevic M.

Wien Klin Wochenschr. 2016 Jun;128(11-12):414-20. doi: 10.1007/s00508-015-0912-6. Epub 2015 Dec 10.

PMID:
26659706
10.

The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.

Scheiner B, Mandorfer M, Schwabl P, Payer BA, Bucsics T, Bota S, Aichelburg MC, Grabmeier-Pfistershammer K, Stättermayer A, Ferenci P, Trauner M, Peck-Radosavljevic M, Reiberger T.

PLoS One. 2015 Nov 23;10(11):e0143429. doi: 10.1371/journal.pone.0143429. eCollection 2015.

11.

Xist imprinting is promoted by the hemizygous (unpaired) state in the male germ line.

Sun S, Payer B, Namekawa S, An JY, Press W, Catalan-Dibene J, Sunwoo H, Lee JT.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14415-22. doi: 10.1073/pnas.1519528112. Epub 2015 Oct 21.

12.

Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation.

Minajigi A, Froberg J, Wei C, Sunwoo H, Kesner B, Colognori D, Lessing D, Payer B, Boukhali M, Haas W, Lee JT.

Science. 2015 Jul 17;349(6245). doi: 10.1126/science.aab2276 aab2276. Epub 2015 Jun 18.

13.

Allelic Imbalance Is a Prevalent and Tissue-Specific Feature of the Mouse Transcriptome.

Pinter SF, Colognori D, Beliveau BJ, Sadreyev RI, Payer B, Yildirim E, Wu CT, Lee JT.

Genetics. 2015 Jun;200(2):537-49. doi: 10.1534/genetics.115.176263. Epub 2015 Apr 9.

14.

Response-guided boceprevir-based triple therapy in HIV/HCV-coinfected patients: the HIVCOBOC-RGT study.

Mandorfer M, Steiner S, Schwabl P, Payer BA, Aichelburg MC, Lang G, Grabmeier-Pfistershammer K, Trauner M, Peck-Radosavljevic M, Reiberger T.

J Infect Dis. 2015 Mar 1;211(5):729-35. doi: 10.1093/infdis/jiu516. Epub 2014 Sep 11.

PMID:
25214517
15.

Letter: comparing scoring systems and outcome of patients admitted to a liver intensive care unit with severe variceal bleeding.

Payer BA, Ferenci P, Zauner C.

Aliment Pharmacol Ther. 2014 Oct;40(7):856. doi: 10.1111/apt.12849. No abstract available.

16.

Coupling of X-chromosome reactivation with the pluripotent stem cell state.

Payer B, Lee JT.

RNA Biol. 2014;11(7):798-807. doi: 10.4161/rna.29779. Epub 2014 Aug 19.

17.

New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.

Schwabl P, Bota S, Salzl P, Mandorfer M, Payer BA, Ferlitsch A, Stift J, Wrba F, Trauner M, Peck-Radosavljevic M, Reiberger T.

Liver Int. 2015 Feb;35(2):381-90. doi: 10.1111/liv.12623. Epub 2014 Jul 9.

PMID:
24953516
18.

Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.

Mandorfer M, Payer BA, Schwabl P, Steiner S, Ferlitsch A, Aichelburg MC, Stättermayer AF, Ferenci P, Obermayer-Pietsch B, Grabmeier-Pfistershammer K, Trauner M, Peck-Radosavljevic M, Reiberger T.

Liver Int. 2015 Mar;35(3):876-85. doi: 10.1111/liv.12615. Epub 2014 Jun 26.

PMID:
24905495
19.

Evaluation of portal hypertension and varices by acoustic radiation force impulse imaging of the liver compared to transient elastography and AST to platelet ratio index.

Salzl P, Reiberger T, Ferlitsch M, Payer BA, Schwengerer B, Trauner M, Peck-Radosavljevic M, Ferlitsch A.

Ultraschall Med. 2014 Dec;35(6):528-33. doi: 10.1055/s-0034-1366506. Epub 2014 May 28.

PMID:
24871695
20.

Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world setting.

Mandorfer M, Payer BA, Niederecker A, Lang G, Aichelburg MC, Strassl R, Boesecke C, Rieger A, Trauner M, Peck-Radosavljevic M, Reiberger T.

AIDS Patient Care STDS. 2014 May;28(5):221-7. doi: 10.1089/apc.2013.0359.

PMID:
24796757
21.

Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.

Schwabl P, Payer BA, Grahovac J, Klein S, Horvatits T, Mitterhauser M, Stift J, Boucher Y, Trebicka J, Trauner M, Angermayr B, Fuhrmann V, Reiberger T, Peck-Radosavljevic M.

J Hepatol. 2014 Jun;60(6):1135-42. doi: 10.1016/j.jhep.2014.01.025. Epub 2014 Feb 13.

PMID:
24530596
22.

Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels.

Mandorfer M, Reiberger T, Payer BA, Breitenecker F, Aichelburg MC, Obermayer-Pietsch B, Rieger A, Puoti M, Zangerle R, Trauner M, Peck-Radosavljevic M.

J Viral Hepat. 2014 Jan;21(1):33-41. doi: 10.1111/jvh.12118. Epub 2013 Aug 1.

PMID:
24329855
23.

Tsix RNA and the germline factor, PRDM14, link X reactivation and stem cell reprogramming.

Payer B, Rosenberg M, Yamaji M, Yabuta Y, Koyanagi-Aoi M, Hayashi K, Yamanaka S, Saitou M, Lee JT.

Mol Cell. 2013 Dec 26;52(6):805-18. doi: 10.1016/j.molcel.2013.10.023. Epub 2013 Nov 21.

24.

Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients.

Strassl R, Reiberger T, Honsig C, Payer BA, Mandorfer M, Grabmeier-Pfistershammer K, Rieger A, Kundi M, Grundtner P, Peck-Radosavljevic M, Popow-Kraupp T.

J Viral Hepat. 2014 Jul;21(7):508-16. doi: 10.1111/jvh.12175. Epub 2013 Sep 24.

PMID:
24112778
25.

Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin.

Mandorfer M, Payer BA, Scheiner B, Breitenecker F, Aichelburg MC, Grabmeier-Pfistershammer K, Rieger A, Trauner M, Peck-Radosavljevic M, Reiberger T.

Liver Int. 2014 Jan;34(1):69-77. doi: 10.1111/liv.12253. Epub 2013 Jul 29.

PMID:
23890125
26.

A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection.

Beinhardt S, Payer BA, Datz C, Strasser M, Maieron A, Dorn L, Grilnberger-Franz E, Dulic-Lakovic E, Stauber R, Laferl H, Aberle JH, Holzmann H, Krall C, Vogel W, Ferenci P, Hofer H.

J Hepatol. 2013 Nov;59(5):972-7. doi: 10.1016/j.jhep.2013.06.028. Epub 2013 Jul 10.

PMID:
23850880
27.

The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.

Mandorfer M, Neukam K, Reiberger T, Payer BA, Rivero A, Puoti M, Boesecke C, Baumgarten A, Grzeszczuk A, Zangerle R, Meyer-Olson D, Rockstroh JK, Trauner M, Pineda JA, Peck-Radosavljevic M.

AIDS. 2013 Nov 13;27(17):2707-14. doi: 10.1097/01.aids.0000432460.44593.ef.

PMID:
23835502
28.

Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).

Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V, Häfner M, Kramer L, Maieron A, Payer B, Reiberger T, Stauber R, Steininger R, Trauner M, Thurnher S, Ulbrich G, Vogel W, Zoller H, Graziadei I; Austrian Society of Gastroenterology and Hepatology.

Wien Klin Wochenschr. 2013 Apr;125(7-8):200-19. doi: 10.1007/s00508-013-0337-z. Epub 2013 Apr 12.

PMID:
23579878
29.

Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.

Reiberger T, Payer BA, Schwabl P, Hayden H, Horvatits T, Jäger B, Hummel T, Mitterhauser M, Trauner M, Fuhrmann V, Angermayr B, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab.

Liver Int. 2013 Apr;33(4):561-8. doi: 10.1111/liv.12101. Epub 2013 Jan 20.

PMID:
23331709
30.

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.

Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H, Lammert F, Trauner M, Peck-Radosavljevic M, Vogelsang H; Vienna Hepatic Hemodynamic Lab.

J Hepatol. 2013 May;58(5):911-21. doi: 10.1016/j.jhep.2012.12.011. Epub 2012 Dec 20.

PMID:
23262249
31.

Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.

Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, Heinisch BB, Trauner M, Kramer L, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab.

Gut. 2013 Nov;62(11):1634-41. doi: 10.1136/gutjnl-2012-304038. Epub 2012 Dec 18.

PMID:
23250049
32.

The influence of portal pressure on the discordance between absolute CD4+ cell count and CD4+ cell percentage in HIV/hepatitis C virus-coinfected patients.

Mandorfer M, Reiberger T, Payer BA, Peck-Radosavljevic M; Vienna HIV & Liver Study Group.

Clin Infect Dis. 2013 Mar;56(6):904-5. doi: 10.1093/cid/cis1017. Epub 2012 Dec 12. No abstract available.

PMID:
23243175
33.

Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.

Mandorfer M, Reiberger T, Payer BA, Ferlitsch A, Breitenecker F, Aichelburg MC, Obermayer-Pietsch B, Rieger A, Trauner M, Peck-Radosavljevic M; Vienna HIV & Liver Study Group.

AIDS. 2013 Jan 14;27(2):227-32. doi: 10.1097/QAD.0b013e32835aa161.

PMID:
23238552
34.

Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.

Kosi L, Reiberger T, Payer BA, Grabmeier-Pfistershammer K, Strassl R, Rieger A, Peck-Radosavljevic M.

J Viral Hepat. 2012 Nov;19(11):801-10. doi: 10.1111/j.1365-2893.2012.01601.x. Epub 2012 Mar 15.

PMID:
23043387
35.

A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.

Reiberger T, Payer BA, Ferlitsch A, Sieghart W, Breitenecker F, Aichelburg MC, Schmied B, Rieger A, Trauner M, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab and Vienna HIV & Liver Study Group.

Antivir Ther. 2012;17(7):1327-34. doi: 10.3851/IMP2349. Epub 2012 Sep 5.

PMID:
22948263
36.

An ex vivo model for imprinting: mutually exclusive binding of Cdx2 and Oct4 as a switch for imprinted and random X-inactivation.

Erwin JA, del Rosario B, Payer B, Lee JT.

Genetics. 2012 Nov;192(3):857-68. doi: 10.1534/genetics.112.144121. Epub 2012 Aug 31.

37.

Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection.

Jaroszewicz J, Reiberger T, Meyer-Olson D, Mauss S, Vogel M, Ingiliz P, Payer BA, Stoll M, Manns MP, Schmidt RE, Flisiak R, Wedemeyer H, Peck-Radosavljevic M, Rockstroh J, Cornberg M.

PLoS One. 2012;7(8):e43143. doi: 10.1371/journal.pone.0043143. Epub 2012 Aug 15.

38.

Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes.

Anguera MC, Sadreyev R, Zhang Z, Szanto A, Payer B, Sheridan SD, Kwok S, Haggarty SJ, Sur M, Alvarez J, Gimelbrant A, Mitalipova M, Kirby JE, Lee JT.

Cell Stem Cell. 2012 Jul 6;11(1):75-90. doi: 10.1016/j.stem.2012.03.008.

39.

Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience.

Reiberger T, Ferlitsch A, Payer BA, Pinter M, Schwabl P, Stift J, Trauner M, Peck-Radosavljevic M.

Wien Klin Wochenschr. 2012 Jun;124(11-12):395-402. doi: 10.1007/s00508-012-0190-5. Epub 2012 Jun 15.

PMID:
22699260
40.

von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.

Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A.

Hepatology. 2012 Oct;56(4):1439-47. doi: 10.1002/hep.25806. Epub 2012 Aug 27.

PMID:
22532296
41.

The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV.

Payer BA, Reiberger T, Breitenecker F, Aichelburg MC, Schuster C, Heil PM, Scherzer TM, Ferenci P, Rieger A, Peck-Radosavljevic M; Vienna HIV & Liver Study Group.

J Infect. 2012 Aug;65(2):142-9. doi: 10.1016/j.jinf.2012.02.014. Epub 2012 Mar 10.

PMID:
22410384
42.

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.

Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab.

J Gastroenterol. 2012 May;47(5):561-8. doi: 10.1007/s00535-011-0517-4. Epub 2011 Dec 15.

PMID:
22170417
43.

IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients.

Payer BA, Reiberger T, Aberle J, Ferenci P, Holzmann H, Rieger A, Peck-Radosavljevic M; Vienna HIV-HCV study group.

Eur J Clin Invest. 2012 Jun;42(6):599-606. doi: 10.1111/j.1365-2362.2011.02623.x. Epub 2011 Nov 25.

PMID:
22117591
44.

Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma.

Stremitzer S, Tamandl D, Kaczirek K, Maresch J, Abbasov B, Payer BA, Ferlitsch A, Gruenberger T.

Br J Surg. 2011 Dec;98(12):1752-8. doi: 10.1002/bjs.7672. Epub 2011 Oct 19.

PMID:
22009385
45.

Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting.

Reiberger T, Obermeier M, Payer BA, Baumgarten A, Weitner L, Moll A, Christensen S, Köppe S, Kundi M, Rieger A, Peck-Radosavljevic M.

Antivir Ther. 2011;16(6):815-24. doi: 10.3851/IMP1831.

PMID:
21900713
46.

X-inactivation and X-reactivation: epigenetic hallmarks of mammalian reproduction and pluripotent stem cells.

Payer B, Lee JT, Namekawa SH.

Hum Genet. 2011 Aug;130(2):265-80. doi: 10.1007/s00439-011-1024-7. Epub 2011 Jun 12.

47.

Concomitant highly active antiretroviral therapy leads to smaller decline and faster recovery of CD4+ cell counts during and after pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus coinfected patients.

Reiberger T, Payer BA, Kosi L, Heil PM, Rieger A, Peck-Radosavljevic M; Vienna HIV Coinfection Study Group.

J Infect Dis. 2011 Jun 15;203(12):1802-6. doi: 10.1093/infdis/jir194.

PMID:
21606538
48.

Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection.

Reiberger T, Rutter K, Ferlitsch A, Payer BA, Hofer H, Beinhardt S, Kundi M, Ferenci P, Gangl A, Trauner M, Peck-Radosavljevic M.

Clin Gastroenterol Hepatol. 2011 Jul;9(7):602-8.e1. doi: 10.1016/j.cgh.2011.03.002. Epub 2011 Mar 10.

PMID:
21397726
49.

Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient.

Payer BA, Reiberger T, Rutter K, Beinhardt S, Staettermayer AF, Peck-Radosavljevic M, Ferenci P.

J Clin Virol. 2010 Oct;49(2):131-3. doi: 10.1016/j.jcv.2010.07.006. Epub 2010 Aug 14.

PMID:
20709593
50.

Phosphorus mobilization in rewetted fens: the effect of altered peat properties and implications for their restoration.

Zak D, Wagner C, Payer B, Augustin J, Gelbrecht J.

Ecol Appl. 2010 Jul;20(5):1336-49.

PMID:
20666253

Supplemental Content

Support Center